Obesity: ANMAT Approves a New Dose of Medication that Expands Possibilities to Customize Treatments
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
The National Administration of Medicines, Food and Medical Technology (ANMAT) approved in Argentina a new weekly dose for the treatment of adults with obesity with or without diabetes. According to one report, the incorporation expands the available alternatives to individualize the treatment of this chronic disease according to the response and objectives of each [...] The entry Approves new dose of an important medication for obesity was first…
The authorization of the 7.2 mg weekly dose extends the therapeutic alternatives for obese adults, with or without type 2 diabetes. Its indication should be done individually and under strict medical supervision. Read more
Noticias Argentinas | Agencia de noticias
elciudadanoweb.comThis is a new alternative for obese adults, which allows doctors to adapt treatment according to the clinical response and objectives of each patient.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
